MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges

AGS Phoolchund, SI Khakoo - Cancers, 2024 - mdpi.com
Simple Summary Metabolic-dysfunction-associated steatotic liver disease (previously known
as non-alcoholic fatty liver disease) is a term for a range of liver conditions in which excess …

MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges

AGS Phoolchund, SI Khakoo - Cancers, 2024 - pubmed.ncbi.nlm.nih.gov
Metabolic-dysfunction-associated steatotic liver disease (MASLD, previously known as non-
alcoholic fatty liver disease (NAFLD)) represents a rapidly increasing cause of chronic liver …

MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges

AGS Phoolchund, SI Khakoo - Cancers, 2024 - search.proquest.com
Metabolic-dysfunction-associated steatotic liver disease (MASLD, previously known as non-
alcoholic fatty liver disease (NAFLD)) represents a rapidly increasing cause of chronic liver …

MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges.

AGS Phoolchund, SI Khakoo - Cancers, 2024 - search.ebscohost.com
Abstract Simple Summary: Metabolic-dysfunction-associated steatotic liver disease
(previously known as non-alcoholic fatty liver disease) is a term for a range of liver …

MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges.

AGS Phoolchund, SI Khakoo - Cancers, 2024 - europepmc.org
Metabolic-dysfunction-associated steatotic liver disease (MASLD, previously known as non-
alcoholic fatty liver disease (NAFLD)) represents a rapidly increasing cause of chronic liver …

MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges.

AGS Phoolchund, SI Khakoo - Cancers, 2024 - go.gale.com
Metabolic-dysfunction-associated steatotic liver disease (previously known as non-alcoholic
fatty liver disease) is a term for a range of liver conditions in which excess fat builds up in the …

[HTML][HTML] MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges

AGS Phoolchund, SI Khakoo - Cancers, 2024 - ncbi.nlm.nih.gov
Metabolic-dysfunction-associated steatotic liver disease (MASLD, previously known as non-
alcoholic fatty liver disease (NAFLD)) represents a rapidly increasing cause of chronic liver …

MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges.

AGS Phoolchund, SI Khakoo - Cancers, 2024 - europepmc.org
Metabolic-dysfunction-associated steatotic liver disease (MASLD, previously known as non-
alcoholic fatty liver disease (NAFLD)) represents a rapidly increasing cause of chronic liver …